A widespread disruption is underway in the form of hybrid work: While some organizations have insisted that workers return to the office full-time, many have transitioned to a new normal where employees spend some days in the office and some days working remotely, with a combination of virtual and in-person meetings and collaboration.
Mark Reisenauer is President of Astellas Pharma US, a $5 billion affiliate of the Tokyo-based pharmaceutical company headquartered in Northbrook, Ill., with 1,000 employees. Astellas is a company committed to improving the health of people around the world through the provision of innovative pharmaceutical products.
Reisenauer has dedicated his career to creating change that positively impacts the lives of patients and their caregivers. Over the past decade, he has helped establish Astellas as a top 25 global pharmaceutical company and build the oncology franchise, which is the company's fastest growing franchise.
Reisenauer also serves on the board of the Pharmaceutical Research and Manufacturers of America (PhRMA), an organization dedicated to advancing policies that ensure continued investment in biopharmaceutical innovation.
CRAIN'S: Why did Astellas choose to adapt its Ways of Working and transition to a hybrid work environment?
MARK REISENAUER: As COVID-19 cases were on the rise, Astellas quickly adopted different working arrangements to ensure the health and safety of employees, while still allowing them to be fully functional in...
A fake BBC News report that falsely accuses Ukrainian President Volodymyr Zelensky of displaying a stolen painting has been circulating on X since April 21. The footage appears to show the Ukraini...